Clinical trial
A Multi-Center Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
NCT01243671 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- June 30, 2013
- Enrollment
- 20 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
intestinal behçet's disease